While most ob/gyns can recite a long list of risk factors for this lethal complication, mounting evidence suggests that maternal hypotension should be taken into account as well.
Clinicians don't appreciate stillbirth as much as they should. Would it surprise you to learn, for instance, that antepartum stillbirths-defined as fetal demise after 20 weeks' gestation and before delivery-account for more perinatal deaths than either complications of prematurity or sudden infant death syndrome?1,2 And despite intensive efforts, about half of all stillbirths remain unexplained.3-5 While hypertensive disorders are well-known causes of adverse pregnancy outcome, including stillbirth, we'd like to consider the far more provocative question: Does low blood pressure increase the risk of this complication?
The perinatal mortality rate in the United States has decreased by 75% since 1950, due primarily to a drop in neonatal mortality. Although fetal deaths also decreased during that time, stillbirths continue to contribute disproportionately to perinatal mortality. In 1998, for example, the neonatal mortality rate in the US was 4.8 per 1,000 births, while the comparable fetal mortality rate was 6.7 per 1,000 births.6
What causes stillbirth?
Physiologic adaptations occur in the maternal cardiovascular system in response to the demands of pregnancy. In healthy normotensive women, blood pressure fluctuates significantly and in predictable ways throughout pregnancy. It falls in early pregnancy and is usually 10 mm Hg below baseline in the second trimester, declining to a mean of 105/60 mm Hg.19-21 The fall in blood pressure is due primarily to a reduction in systemic vascular resistance. Both low resistance in the uteroplacental circulation and systemic vasodilatation contribute to the decline in vascular resistance. We don't fully understand the factors responsible for this vasodilatation but they include decreased vascular responsiveness to the pressor effects of angiotensin II and norepinephrine, increased release of endothelial prostacyclin, enhanced nitric oxide production, and a direct effect of estrogen, progesterone, prolactin, and related hormones.
Blood pressure reaches a nadir around 20 to 28 weeks and returns to baseline at term.22-24 Keep in mind, however, that blood pressure measurements are subject to change depending on the technique and instrument used and positioning of the patient.24-26 For the sake of consistency and standardization, measurements in pregnancy should always be taken from the brachial artery at the level of the heart with the patient in the sitting position at rest for at least 5 minutes using an appropriate-sized manual cuff and listening for the 5th Korotkoff's sound (disappearance, not muffling) to designate diastolic pressure.23,27,28
Blood pressure abnormalities and adverse pregnancy outcomes
A sustained elevation in blood pressure of ≥ 140 mm Hg systolic, ≥90 mm Hg diastolic, or both should be regarded as abnormal at any stage of pregnancy, and may represent chronic hypertension, preeclampsia, or gestational non-proteinuric hypertension.26,29 On the other hand, conventional wisdom suggests that low blood pressure in pregnancy is reassuring, despite the fact that the data supporting this view are limited. In fact, several studies suggest that low blood pressure in the third trimester increases the threat of both stillbirth and growth restriction.17,18,30-32
Unlocking HPV prevention: Insights from 2022 data on vaccination trends
May 14th 2024Explore the latest findings revealing vaccination rates among children aged 9 to 17 years, uncovering demographic disparities and highlighting the crucial role of vaccination in combating human papillomavirus infections and related health risks.
Read More
Prenatal cannabis and nicotine use linked to adverse pregnancy outcomes
May 14th 2024A recent study highlights the heightened risks of maternal and neonatal morbidity and mortality associated with combined cannabis and nicotine use during pregnancy, urging further investigation into their impact on short- and long-term outcomes.
Read More
Understanding pediatric STIs: Trends, management, and more
May 10th 2024Dive into the rising prevalence of sexually transmitted infections among adolescents and young adults, exploring educational gaps, vaccination rates, and the imperative need for open conversations between patients and health care providers to combat stigma and enhance preventive care.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More